NeuroSense Therapeutics (NRSN) Non-Current Assets (2020 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Non-Current Assets came in at $250000.0 in Q4 2025, up 44.51% year-over-year from $173000.0 in Q4 2024, and up 95.31% quarter-over-quarter from $128000.0 in Q2 2025.
NeuroSense Therapeutics (NRSN) Non-Current Assets (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Non-Current Assets across 6 years of filings, most recently posting $250000.0 for Q4 2025.
- In Q4 2025, Non-Current Assets rose 44.51% year-over-year to $250000.0; the TTM figure through Dec 2025 stood at $250000.0 (up 44.51% YoY), while the FY2025 annual figure was $250000.0, up 44.51% from the prior year.
- Non-Current Assets came in at $250000.0 for Q4 2025 at NeuroSense Therapeutics, up from $128000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $349000.0 in Q2 2022 to a low of $19000.0 in Q4 2021.
- Average Non-Current Assets over 5 years is $251400.0, with a median of $269000.0 recorded in 2023.
- Year-over-year, Non-Current Assets soared 1668.42% in 2022 and plunged 42.34% in 2025.
- Over 5 years, Non-Current Assets stood at $19000.0 in 2021, then soared by 1668.42% to $336000.0 in 2022, then slipped by 19.94% to $269000.0 in 2023, then slumped by 35.69% to $173000.0 in 2024, then surged by 44.51% to $250000.0 in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $250000.0 in Q4 2025, $128000.0 in Q2 2025, and $173000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 5.15 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 1.96 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 564.41 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | 250,000.00 |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 250,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 199,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | 281,000.00 |
| Jun 30, 2023 | 307,000.00 |
| Mar 31, 2023 | 317,000.00 |
| Dec 31, 2022 | 336,000.00 |
| Sep 30, 2022 | 338,000.00 |
| Jun 30, 2022 | 349,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 13,000.00 |
NeuroSense Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();